HM PAYSON & CO - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 164 filers reported holding BLUEBIRD BIO INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
HM PAYSON & CO ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$4,864
+47.8%
1,600
+60.0%
0.00%
Q2 2023$3,290
+3.5%
1,0000.0%0.00%
Q1 2023$3,180
-54.0%
1,0000.0%0.00%
Q4 2022$6,920
+15.3%
1,0000.0%0.00%
Q3 2022$6,000
+50.0%
1,0000.0%0.00%
Q2 2022$4,000
-20.0%
1,0000.0%0.00%
Q1 2022$5,000
-50.0%
1,0000.0%0.00%
Q4 2021$10,000
-47.4%
1,0000.0%0.00%
Q3 2021$19,000
+18.8%
1,000
+100.0%
0.00%
Q2 2021$16,000
-11.1%
500
+49.7%
0.00%
-100.0%
Q3 2020$18,0003340.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q3 2022
NameSharesValueWeighting ↓
AlpInvest Partners B.V. 46,264$3,958,0007.80%
RTW INVESTMENTS, LP 151,594$12,969,0004.03%
APIS CAPITAL ADVISORS, LLC 30,870$2,640,0003.65%
Parametrica Management Ltd 4,084$349,0002.20%
Eventide Asset Management 419,600$35,897,0002.09%
RA Capital Management 167,367$14,318,0002.06%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 483,000$41,321,0001.60%
Taylor Wealth Management Partners 38,184$3,267,0001.58%
Orbimed Advisors 1,188,900$101,710,0001.03%
CABOT WEALTH MANAGEMENT INC 34,195$2,925,0000.81%
View complete list of BLUEBIRD BIO INC shareholders